Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
Become a Member | Sign in
Home>Events>This Event
  Events - May 2013

3-day Agilent H4063A Mass Spectral Interpretation course

13 May 2013 - 15 May 2013 - Milton Keynes, UK

Bookmark and Share

What will I learn on this course?

This three-day course is designed to present the fundamental concepts necessary to obtain high-quality data in SCAN mode from a GC-MS System for spectral interpretation purposes. The most commonly employed tools used in identifying compounds based on their mass spectra are introduced, the physical reasons for their efficiency explained, and their use reinforced through problem solving. The most common decomposition mechanisms responsible for fragment ions will also be introduced. This course is classroom based and combines a mixture of presentations to introduce the concepts with a high proportion of lab exercises to reinforce the knowledge.

If you wish to delve further into mass spectrometry in order to identify unknown spectra and evaluate MS library database search results using a modern mass spectrometer and data system, then this course for you. This provides only an introduction to mass spectral interpretation. 

Is this course for me?

This course is recommended for those who have a good background in organic chemistry and at least six months experience as a GC-MS operator 

Course Venue

Agilent Centre of Excellence, The Open University, Milton Keynes, UK

More Information

For more information or a course outline, please email

Further information
Scientific News
Atriva Therapeutics GmbH Develops Innovative Flu Drug
Highly effective against seasonal and pandemic influenza.
Study Removes Cancer Doubt for Multiple Sclerosis Drug
Researchers from Queen Mary University of London are calling on the medical community to reconsider developing a known drug to treat people with relapsing Multiple sclerosis after new evidence shows it does not increase the risk of cancer as previously thought.
New Hope for Personalized Treatment of Eczema
Pharmaceutical researchers at Oregon State University have developed a new approach to treat eczema and other inflammatory skin disorders that would use individual tests and advanced science to create personalized treatments based on each person's lipid deficiencies.
Inroads Against Leukaemia
Potential for halting disease in molecule isolated from sea sponges.
Researchers Disguise Drugs As Platelets to Target Cancer
Researchers have for the first time developed a technique that coats anticancer drugs in membranes made from a patient’s own platelets.
HIV Patients Should Be Included in Early Clinical Trials of Anti-TB Drugs
Tuberculosis is the number one cause of death in HIV-infected patients in Africa and a leading cause of death in this population worldwide.
Combination Drug Therapy Shrinks Pancreatic Tumors In Mice
Two drugs that affect the structure and function of DNA have been found to block the growth of pancreatic tumor cells in mice, researchers hope the drugs can soon be tested in humans with the disease.
Seeking A Better Way To Design Drugs
NIH funds research at Worcester Polytechnic Institute to advance a new chemical process for more effective drug development and manufacturing.
Old Drug Performs New Tricks
Cambridge-led research reveals the powers of a "wonder drug" that has lain under the noses of doctors for 50 years.
Diabetes Drugs May Actually Release Sugar Into the Blood
A family of drugs used to treat Type 2 diabetes could promote the release of sugars into the blood - something the drugs are supposed to prevent, Cambridge scientists have claimed.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,600+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos